Patents by Inventor Judith A. Fox

Judith A. Fox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110059104
    Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: July 29, 2010
    Publication date: March 10, 2011
    Applicant: Genentech, Inc.
    Inventors: Enrique Escandon, Sean K. Kelley, Hong Xiang, Judith A. Fox
  • Publication number: 20090203104
    Abstract: The present invention relates to TAB molecules, ADEPT constructs directed against TAG-72, and their use in therapy.
    Type: Application
    Filed: April 21, 2006
    Publication date: August 13, 2009
    Inventors: Judith A. Fox, M. Harunur Rashid, Martin Roberge, Volker Schellenberger
  • Publication number: 20090169569
    Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: September 12, 2008
    Publication date: July 2, 2009
    Applicant: Genentech, Inc.
    Inventors: Enrique Escandon, Sean K. Kelley, Hong Xiang, Judith A. Fox
  • Publication number: 20080096810
    Abstract: The present invention relates to CAB molecules, ADEPT constructs directed against CEA, and their use in therapy.
    Type: Application
    Filed: April 12, 2005
    Publication date: April 24, 2008
    Inventors: Judith A. Fox, Fiona A. Harding, Rashid M. Harunur, Volker Schellenberger
  • Publication number: 20060141456
    Abstract: The present invention provides methods and compositions for milieu-dependent binding of a targeted agent to a target, for example, for the milieu-dependent binding of a diagnostic or therapeutic molecule to a diseased, injured or infected organ, tissue or cell.
    Type: Application
    Filed: June 9, 2003
    Publication date: June 29, 2006
    Inventors: Cynthia Edwards, Judith Fox, Christopher Murray, Volker Schellenberger, Robert Tressler
  • Publication number: 20050095238
    Abstract: Disclosed is a method for treating a human having a disease associated with leukocyte infiltration of mucosal tissues, comprising administering to said human an effective amount of a human or humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for ?4?7 integrin. Preferably, no more than about 8 mg immunoglobulin or fragment per kg body weight are administered during a period of about one month.
    Type: Application
    Filed: December 15, 2003
    Publication date: May 5, 2005
    Applicants: Millennium Pharmaceuticals, Inc., Genentech, Inc.
    Inventors: Lee Brettman, Judith Fox, David Allison
  • Publication number: 20040005314
    Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
    Type: Application
    Filed: January 23, 2003
    Publication date: January 8, 2004
    Inventors: Enrique Escandon, Sean K Kelley, Hong Xiang, Judith A Fox
  • Publication number: 20010046496
    Abstract: Disclosed is a method for treating a human having a disease associated with leukocyte infiltration of mucosal tissues, comprising administering to said human an effective amount of a human or humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for &agr;4&bgr;7 integrin. Preferably, no more than about 8 mg immunoglobulin or fragment per kg body weight are administered during a period of about one month.
    Type: Application
    Filed: December 27, 2000
    Publication date: November 29, 2001
    Inventors: Lee R. Brettman, Judith A. Fox, David Edward Allison